Schistosoma mansoni and
host-parasite interactions

Saskia de Walick

Chapter 4
Binding of von Willebrand factor and plasma proteins to the eggshell of Schistosoma mansoni

Saskia deWalickD1, Paul J. HensbergenD2, Michiel L. BexkensD1, Christina Grosserichter-WagenerD1, Cornelis H. HokkeD3, André M. DeelderD3, Philip G. de GrootD4, Aloysius G.M. TielensD1, Jaap J. van HellemondD1

International Journal for Parasitology 2014, 44:263-268.



Affiliations

D1
Department of Medical Microbiology and Infectious Diseases, Erasmus MC, Rotterdam, The Netherlands
D2
Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands
D3
Department of Parasitology, Center for Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands
D4
Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, The Netherlands

Abstract:

Schistosoma mansoni eggs have to cross the endothelium and intestinal wall to leave the host and continue the life cycle. Mechanisms involved in this essential step are largely unknown. Here we describe direct binding to the S. mansoni eggshell of von Willebrand factor and other plasma proteins involved in haemostasis. Using deletion-mutants, we demonstrated that it is the A1 domain of von Willebrand factor that binds to the eggshell. Our results suggest that binding of plasma proteins to the eggshell promotes binding to the endothelium, initiating the passage of the egg through the blood-vessel wall to be excreted in the end.

Main article

Schistosoma spp. are helminths causing the tropical disease schistosomiasis. An estimated 200 million people are affected, most of them living in sub-Saharan Africa (74). These parasites penetrate their human host through the skin after which the cercariae transform into schistosomula that subsequently enter the circulation. In the case of Schistosoma mansoni, male and female worms meet in the portal vein, where they pair and mature before moving to the mesenteric veins, their final habitat (74). Mature female worms excrete approximately 300 eggs per day, which is about one every 5 minutes (32). In order to complete the schistosome life-cycle, the eggs have to be excreted with the faeces. Therefore, eggs have to cross the blood-vessel wall as well as the intestinal wall. Many eggs fail to extravasate and are transported by the blood flow to the liver where they get stuck and induce granuloma formation, fibrosis of the liver and portal hypertension. These non-excreted eggs are the major cause of morbidity in schistosomiasis.

Eggs have a rigid shell structure of cross-linked proteins and thus cannot propel themselves (48). Therefore, eggs depend on external forces in order to cross the host tissues. Mechanisms involved in excretion of eggs are largely unknown, even though this is an essential step in the life-cycle of schistosomes. Eggs of several schistosome species have a sharp spine and it could be imagined that the presence of this spine aids in passing through the obstructing structures of the host (89). However, eggs of Schistosoma japonicum and Schistosoma mekongi lack a sharp spine, which makes this theory unrealistic. It is known that the process of excretion is partly dependent on the host immune reaction directed towards eggs (49), but additional mechanisms are likely to be involved.

It has been demonstrated that eggs attach to endothelium and that endothelial cells actively migrate over the eggs (64). The endothelial surface-adhesion molecules, ICAM-1, E-selectin and VCAM-1, and surface exposed Lewis X glycans on S. mansoni eggs play an important role in egg adhesion to the vascular endothelium (98). In addition, plasma factors enhance egg attachment to endothelial cells in vitro and platelets have a role in extravasation and excretion in vivo (64,125,126). Furthermore, schistosome eggs were also shown to be a potent and direct activator of platelets and platelets were shown to adhere en masse to eggs in vitro (125,203). Activated platelets aggregate and stimulate secondary coagulation (the plasma clotting factor cascade) which results in fibrin fibre formation to stabilise the platelet plug. Apparently, there is an interaction of the schistosome eggshell with the host haemostatic system, but the molecular structures involved in the activation of the haemostatic system are unknown.

We hypothesised that the egg probably attracts host proteins and host cells in order to hold onto the vessel wall and help passage through the endothelium and the gut wall, allowing excretion from the host and continuation of the life cycle. Therefore, we analysed the interaction of S. mansoni eggshells with von Willebrand factor (VWF), as this clotting factor is crucial for anchoring clotting material to damaged or activated surfaces of the blood vessel, and VWF could thus play an essential role in egg extravasation. VWF is an adhesive glycoprotein of 250 kD which forms multimers that can be extremely large and consist of over 80 subunits, resulting in a multimer of over 20 mega-Dalton. VWF contains many binding domains that can connect platelets to clotting factors and injured surfaces of the endothelium (105,159). VWF binds platelet glycoprotein Ib (GPIb) on platelets which are thereby activated and initiate clot formation.

The presence of VWF on S. mansoni eggs isolated from collagenase digested livers of infected hamsters was demonstrated by immunofluorescence (Fig. 4.1A). As these eggs were directly obtained from perfused livers, this demonstrates that VWF binding occurred in vivo in the blood vessel.

Schistosome eggs were also incubated in vitro with purified human VWF. We used both untreated eggs and stripped eggs. From stripped eggs, all non-covalently bound proteins were removed by a procedure which includes multiple washes with high salt conditions, detergents, urea and even boiling in SDS, in order to be entirely sure that no host factors remained on the surface of the schistosome egg (47). Both untreated (Fig. 4.1C) and stripped eggs (Fig. 4.1D) bound purified human VWF in vitro, demonstrating the direct interaction between VWF and the eggshell. The binding of VWF to eggs could also be demonstrated at a more quantitative level using stripped eggshell fragments and enhanced chemiluminescence (ECL) measurements (Fig. 4.1H).

We also incubated stripped schistosome eggs for 1 min with citrate plasma from healthy adult human volunteers, obtained after informed consent. Binding of VWF to eggs was then demonstrated by immune fluorescence (Fig. 4.1F and G). This result demonstrated that VWF in the presence of all other plasma proteins still binds to the schistosome eggs, although the punctuated fluorescence pattern suggests that other plasma proteins compete for egg binding, or that other plasma proteins shield bound VWF prohibiting its detection by immune fluorescence. Altogether these results demonstrate that there is a direct interaction between schistosome eggshells and VWF. To determine which VWF domain is involved in eggshell binding, we incubated eggs with recombinant human VWF of which either the A1 (97), A2 (95) or A3 domain (96) was deleted. Reduced VWF binding was only observed with the A1 domain-deleted VWF, but not with VWF lacking the A2 or A3 domain (Fig. 4.1I). This indicates that VWF binds eggshells with its A1 domain. Domain A1 of VWF is a relatively small part of VWF as it comprises circa 250 amino acids, which is approximately 15% of the entire VWF protein (97). In addition, deletion of the A1 domain does not affect the structure and function of the other domains in VWF (95,96,97). Hence, the dependence on a small domain of VWF for its binding to schistosome eggs suggests a specific interaction.

The A1 domain of VWF also binds GPIb, a glycosylated receptor on platelets. Since the eggshell contains glycan structures as well (47), we hypothesised that eggshell glycans may play a role in the binding of VWF. However, we could not find indications for glycan-mediated VWF binding to eggshells. Treatment of eggshells with glycosidases did not reduce VWF binding (data not shown), but these treatments did not remove all glycan structures either and therefore these experiments were inconclusive. Blocking of glycan access with monoclonal antibodies against schistosome glycans (291-2G3-A, 114-3A5, 128-4F9-A (which bind to Galβ1-4(Fucα1-3)GlcNAc (Lewis X)), 273-3F2 (which binds to GalNAcβ1-4GlcNAc (LDN)) (192) and 114-4D12 (which binds to Fucα1-2Fucα1-3 (DF) termini) (148)) had no effect on the binding of VWF to eggshells (data not shown). Furthermore, treatment of eggshells with periodate, which disrupts glycan structures, did not reduce VWF binding (data not shown). In conclusion, VWF binds directly to eggshells through its A1 domain, most likely in a non-glycan-mediated manner.

Figure 4.1: von Willebrand factor binding to Schistosoma mansoni eggshells. Eggs of a Puerto Rican strain of S. mansoni maintained in Golden hamsters for which animal ethics was approved (licence EUR1860-11709), were isolated 49 days p.i. as described previously (47). Eggshell fragments were prepared by crushing eggshells in a micro-dismembrator S (Braun Biotech Int., Melsungen, Germany). "Stripped eggs" and "stripped eggshell fragments" were prepared by removal of non-covalently attached host material from isolated eggs or eggshell fragments by consecutive washes with 2 M NaCl in PBS, 1% (v/v) Triton X-100 in PBS, 8 M urea with 0.6% β-mercaptoethanol in PBS, and finally with 1% (w/v) SDS at 95 °C for 30 min (47). Untreated schistosome eggs isolated from livers were incubated with polyclonal anti-von Willebrand factor rabbit antibody (Dako) (A) or PBS (B) for 1 h. Subsequently, for immune fluorescence microscopy these eggshells were washed with PBS and stained with Alexa 633 conjugated anti-rabbit IgG antibody (Invitrogen, USA). Fluorescence microscope images were taken using Cell F software (Olympus, Germany). Untreated eggs (C) or stripped eggs (D-G) were incubated with 500 μl of PBS/BSA/Tween (E, G), or PBS/BSA/Tween with purified human von Willebrand factor (0.2 μg/ml) (C and D), or plasma using citrate as anticoagulant (F). After incubation, the eggshells were washed three times with PBS and then stained for von Willebrand factor binding as described above using a polyclonal anti-von Willebrand factor rabbit antibody (Abcam, UK). Representative pictures from at least two independent experiments show the immune staining for von Willebrand factor (C-G). To quantify bound von Willebrand factor (H and I), stripped eggshell fragments were incubated with or without purified human von Willebrand factor (H) or with recombinant deletion mutants of von Willebrand factor (I), after which the eggshell fragments were washed with PBS, incubated with anti-von Willebrand factor antibody (Abcam) for 1 h and subsequently incubated with horseradish peroxidase conjugated anti-rabbit immunoglobulin antibodies (Dako, Glostrup, Denmark). The eggshell fragments were then incubated in enhanced chemiluminescence detection reagents (Pierce, USA) and dotted on transparent sheets. Chemiluminescence was captured with Alliance 2.7 (Uvitec, UK) and intensity was determined using Image J software. The amount of eggshell material was quantified by measuring scattering at 655 nm (OD 655). von Willebrand factor binding was normalised for the amount of eggshells by expression in arbitrary units ECL/OD655. The fluorescence signal in the presence of added von Willebrand factor was set to 100%; data from 12 experiments (mean + S.D.) (H). Eggshells were also incubated with recombinant deletion mutants of human von Willebrand factor lacking the A1, A2 or the A3 domain, respectively (I). enhanced chemiluminescence signal of full-length von Willebrand factor was set to 100%, data from three independent experiments (mean + S.D.). Magnification in A-E is identical (bar represents 100 μm) and higher than in F and G (bar represents 50 μm).

When eggs are laid by the female schistosome in the circulation of the host, they immediately come into contact with circulating plasma proteins. We hypothesised that, next to VWF, other plasma proteins involved in fibrin formation, platelet activation and aggregation, bind to eggshells. To test this, we incubated stripped eggshell fragments with plasma and subsequently washed those six times with PBS. Thereafter, bound plasma proteins were released by boiling the eggshells in Laemmli buffer. Released proteins were analysed by SDS-PAGE together with a lane of diluted plasma (Fig. 4.2). A clear difference in protein band pattern was observed between plasma and plasma proteins bound to schistosome eggshell fragments, especially in the high molecular weight range, demonstrating selective binding of certain plasma proteins to eggshells. Following trypsin digestion and LC-MS/MS analysis, the identified proteins in both samples were compared (Table 4.1 and Supplementary Table S1). The high molecular weight plasma protein which specifically bound to eggshells (gel slices 1 and 2) was identified as fibronectin. Although the pattern of protein bands between approx. 50-75 kDa in plasma was similar to the pattern of proteins bound to eggshells, the major proteins in these gel slices were different. In this respect it is noteworthy that albumin, the major plasma protein, could hardly be detected among the proteins bound to eggshells. This validates the selectivity of the binding. The plasma proteins specifically bound to eggshells in the molecular weight region of albumin consisted mainly of fibrinogen (gel slices 5-7). Fibrinogen is a haemostatic protein and is the precursor of fibrin. When cross-linked, fibrin networks reinforce a platelet plug. Similar to fibrin, fibronectin plays an essential role in wound healing and blood clot formation.

Figure 4.2: Specific human plasma protein binding to Schistosoma mansoni eggshells. Blood was freshly drawn from human volunteers in containers containing citrate as anti-coagulant and spun for 10 min at 1200g to obtain platelet-poor plasma. Stripped S. mansoni eggshell fragments were incubated for 1 h with 1 ml of this platelet-poor plasma. After incubation, the eggshell fragments were washed six times with PBS, boiled in Laemmli buffer and run through 12% SDS-PAGE (lanes eggs + plasma), with a control lane containing 10 µl of the used plasma diluted 1:200 in PBS (lane plasma 1:200). Molecular weight marker is shown. Slices were cut from the gel as indicated and numbers correspond to the proteomics data provided in Table 4.1 and Supplementary Table  S1.


Table 4.1: List of main proteins in human plasma versus proteins of human plasma bound to Schistosoma mansoni eggshells. The numbers refer to the gel slices cut from SDS-PAGE as shown in Fig. 4.2. Proteins were in-gel digested with trypsin and subsequently analysed by LC-ion trap MS/MS as described previously (208). Spectra were searched against the human (UniProt) and schistosome (Schistosoma mansoni, release 4.0 h at www.genedb.org) database using the Mascot search algorithm (version 2.2.07). To examine the major differences between protein hits in corresponding bands, only proteins with at least four unique peptides with a peptide score >30 were considered. For each gel slice the most abundant proteins identified are listed, with a maximum of three, ranked by the number of peptides detected for each protein. For a comprehensive overview of the protein identification data, see Supplementary Table S1.
Total plasma proteins Eggshell-bound plasma proteins
Gel slice
number
Protein name Peptides
detected
Protein name Peptides
detecteda
1 Albumin 19 Fibronectin 1 80
2 Albumin 22 Fibronectin 1 139
Fibronectin 1 13 Talin 1 7
Alpha-2-macroglobulin 11 -
3 Albumin 36 Fibronectin 1 34
Alpha-2-macroglobulin 25 Collagen, type II, alpha 1 5
Ceruloplasmin (ferroxidase) 11 -
4 - Fibronectin 1 9
5 Albumin 64 -
Serotransferrin 26 -
6 Albumin 132 Fibrinogen alpha chain 57
Fibrinogen alpha chain 15 Vitronectin 14
Uncharacterised protein 8 Albumin 14
7 Albumin 42 Fibrinogen beta chain 30
Alpha-1-antitrypsin 28 Fibrinogen alpha chain 23
Ig gamma-1 chain C region 14 Uncharacterised protein 13
8 - Fibrinogen gamma chain 32
- Fibrinogen alpha chain 18
- Actin, beta 7
9 Albumin 19 Actin, beta 27
- Apolipoprotein A-IV 12
- Fibronectin 1 12
10 Albumin 25 Fibrinogen alpha chain 10
Haptoglobin 16 -
Apolipoprotein A-IV 4 -
11 Albumin 8 Clusterin 15
- Apolipoprotein E 10
- Fibrinogen alpha chain 9
12 Albumin 9 Apolipoprotein E 34
Apolipoprotein E 6 Fibrinogen alpha chain 10
Fibrinogen alpha chain 6 Fibrinogen gamma chain 10
13 Uncharacterised protein 12 -
14 Albumin 11 -
15 Apolipoprotein A-I 11 -
a Average of two independent experiments.

The set of proteins bound to eggshell was also enriched in actin and talin. These cytoskeleton proteins probably originate from the remaining platelets in the platelet-poor plasma. This is in accordance with previous reports which show that platelets bind very well to eggshells (203). We also observed an enrichment of apolipoproteins E and A-IV in the set of proteins that bound to eggshells (Table 1). In plasma, Apo-IV is present on chylomicrons, whereas Apo E is present on chylomicrons and on intermediate-density lipoproteins (IDLs). Their presence in the set of proteins bound to eggshells could be a result of binding of lipoproteins to eggshells. It is known that adult worms have a low-density lipoprotein (LDL)-receptor-like protein on their tegument (158) and that the worms bind LDL (34). The binding of LDL probably helps the adult worms to mask their antigens and hence hide from the immune system. However, on eggshells no LDL-receptor-like protein is known to be present.

In contrast to the immune fluorescence experiments, the proteome analysis of bound plasma proteins did not reveal VWF as a protein bound to schistosome eggs. Fluorescence is a highly sensitive detection method compared with our proteomic workflow. Mass spectrometry detects the most abundant peptides of a trypsin digest of a protein sample, and thus this technique will only show the proteins mostly present in the analysed material. Therefore, absence of detection by this method cannot be interpreted as an indication that the protein in question is not present. Of note, the plasma concentration of VWF (approximately 10 µg/ml) is very low compared with that of fibrinogen and fibronectin (2-4 mg/ml, 0.3-0.4 mg/ml, respectively). These plasma components each bound to the eggshell and were extremely enriched from plasma compared with albumin and other plasma proteins, but the unfavorable concentration ratio of VWF to fibrinogen and fibronectin on the eggshell seems to have left VWF undetectable by proteomics. The near absence of albumin in the proteins bound to eggshells further demonstrates the specificity of the binding of other plasma proteins to S. mansoni eggshells. Moreover, the binding efficiencies and kinetics of VWF compared with the other possibly competing eggshell binding proteins identified in our proteomics experiments may also have played a role.

To check whether all eggshell bound proteins were from the host and not from the parasite itself, the mass spectrometric data were also searched against the schistosome database. The only schistosome protein found in this analysis was actin, but all identified peptides showed complete homology to human actin. As no schistosome-specific peptides derived from actin were observed, it is likely that the human plasma and not the schistosome itself is the source of the actin found. Altogether, the set of eggshell-binding plasma proteins is indicative of fibrin formation and platelet binding to eggshell.

Our results demonstrate that the schistosome eggshell binds the plasma proteins, VWF, fibrinogen and fibronectin, which play an essential role in clot formation. The main function of VWF is binding to other proteins by protein-protein interaction, for which VWF comprises many binding domains. Upon injury VWF plays an important role in platelet-vessel wall adhesion by binding both platelets (via GPIb and GPIIb-IIIa) and the extracellular matrix of the damaged endothelium exposing collagen and fibrin. Binding of VWF to the GPIIb-IIIa complex, which is exposed on activated platelets only, also plays a role in platelet cross-linking and platelet plug expansion (105). Direct binding of VWF to the eggshell by the A1 domain may thus have two effects. VWF may be directly involved in the binding of eggs to the endothelium by forming a bridge between the eggshell and the extracellular matrix. Indirectly, binding of VWF in combination with the binding of platelets (203) may induce platelet adhesion, platelet activation and secondary haemostasis, allowing the formation of a stable clot. In turn, this should facilitate a firm binding of the egg to the endothelium. Next to induction of clot formation, the schistosome egg also contains fibrinolytic capacity, as it has been shown that soluble extracts of eggs contain a plasmin-like fibrinolytic enzyme activity that could counteract uncontrolled thrombogenesis (51).

Coagulation normally occurs in the case of bleeding, when endothelium is damaged and extracellular matrix is exposed to which VWF can bind. Damage to the endothelium is in itself an activator of platelets and blood coagulation, as are shear stress and turbulence (177). In case of schistosomiasis, shear stress can be caused by the presence of the relatively large worms and eggs. Attachment of adult worms to the endothelium may cause endothelial damage that leads to activation of endothelial cells (168). As coagulation is initiated on eggshells in the near presence of damaged and activated endothelium, VWF bound to the egg may anchor the eggshell to the endothelium, after which platelet aggregation and fibrin clot formation can stabilise the binding.

Extravasation is the first step of excretion and is likely to occur rapidly, before eggs have fully matured and start secreting enzymes and other material. In vitro adhesion of eggs to endothelium takes place within 2 h (98,126). Within 4 h after adhesion to the vascular endothelium, endothelial cells actively migrate over the eggs (64). This way the eggs are removed from the blood vessel. The binding site by which VWF binds to S. mansoni eggs is not easy to resolve experimentally, as this target cannot be isolated because the eggshell is composed of a heavily cross-linked protein structure (48). Furthermore, VWF is a very large protein that has no catalytic activity and its primary function is binding to other proteins via protein-protein interactions. These interactions do not resemble classical receptor-ligand interactions, but are rather complex protein-protein interactions with induced conformational changes. In addition, VWF comprises many different domains for protein-protein interactions and even domain A1, which is crucial for binding to schistosome eggs, binds to a large variety of structures, such as glycoprotein Ib (GPIb), Staphylococcus protein A, Snake Venom Metalloproteinase, collagen and heparin (156). For these reasons, the molecular mechanisms by which VWF binds to most other well-known interacting partners has not yet been resolved, and this prohibits the identification of potential VWF binding sites in the schistosome eggshell on the basis of structural homology to a known target.

In conclusion, our data demonstrated that eggshells of S. mansoni bind a specific set of plasma proteins, including VWF. We suggest that binding of plasma proteins to eggshells is physiologically relevant and a crucial step in extravasation as it promotes binding to damaged or activated endothelium. It thereby prevents eggs being swept into the circulation and it facilitates egg extravasation from the blood vessel, which is the first step in excretion of the egg.

Acknowledgements

We thank Irina Dragan (Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands) for expert technical support.


Supplementary data

Table S1: List of proteins identified in human plasma versus proteins of human plasma bound to Schistosoma mansoni eggshells. The band numbers (BN) refer to the gel slices cut from SDS-PAGE as shown in Fig. 4.2. For each gel slice all protein identifications with at least four unique peptides are listed. PC, protein coverage; TP, total number of peptides; UP, number of unique peptides.
Band
number
Plasma Eggs1 Eggs2
Protein name PCTPUP Protein name PCTPUP Protein name PCTPUP
1 Albumin21.81914 Fibronectin 120.54729 Fibronectin 132.011256
1 Inter-alpha (Globulin) inhibitor H24.354 Fibrinogen alpha chain6.966
1 Collagen, type II, alpha 14.865
2 Serum albumin25.32214 Fibronectin 138.416066 Fibronectin 130.911751
2 Alpha-2-macroglobulin8.01111 Talin 1 5.598 Talin 1 3.45 5
2Fibronectin 17.11311
3Serum albumin36.53621Fibronectin 111.82620Fibronectin 115.24230
3Alpha-2-macroglobulin15.82522Collagen, type II, alpha 12.964Collagen, type II, alpha 12.944
3Ceruloplasmin (ferroxidase)11.51110Talin 11.544
3Pregnancy zone protein8.466
3Complement C33.754
4Fibronectin1 2.875Fibronectin 14.9118
4Fibrinogen alpha chain4.744
5Serum albumin49.66429
5Serotransferrin33.42621
5Ig mu chain C region18.187
5Complement C34.955
6Serum albumin75.913246Fibrinogen alpha chain30.64928Serum albumin32.82116
6Fibrinogen alpha chain22.51514Albumin (Fragment)22.765Fibrinogen alpha chain30.96531
6Uncharacterized protein12.887Vitronectin19.7149Vitronectin16.7148
6Fibronectin 13.955Fibronectin 14.998
6Collagen, type II, alpha 13.554
7Alpha-1-antitrypsin51.22817Fibrinogen beta chain41.13322Fibrinogen beta chain35.62719
7Serum albumin40.14221Fibrinogen gamma chain30.21712Uncharacterized protein19.587
7Ig gamma-1 chain C region36.11410 Fibrinogen alpha chain27.02722Fibrinogen alpha chain19.21916
7Fibrinogen beta chain22.81410Albumin20.7149Fibrinogen gamma chain16.586
7Ig alpha-1 chain C region15.664Vitronectin16.776Fibronectin 15.166
7Fibronectin 15.899
8Fibrinogen gamma chain42.73417Fibrinogen gamma chain34.73013
8Fibrinogen alpha chain23.22016Actin, beta19.177
8Actin, beta19.166Fibrinogen alpha chain16.71612
8Fibrinogen beta chain13.244Fibrinogen beta chain16.566
8Albumin12.597Uncharacterized protein10.076
8Fibronectin 19.71816
9Serum albumin25.11913Actin, beta37.03119Fibronectin 17.0129
9Apolipoprotein A-IV21.7108Actin, beta32.22217
9Fibrinogen alpha chain21.71412Apolipoprotein A-IV22.7139
9Fibronectin 16.51210Fibrinogen alpha chain9.855
9Fibronectin 12.976
10Serum albumin26.62514Fibrinogen alpha chain4.284Fibrinogen gamma chain10.2116
10Haptoglobin19.4168Clusterin9.8137
10Apolipoprotein A-IV10.144Fibrinogen alpha chain8.5116
10Fibrinogen alpha chain5.575Fibronectin 12.866
10Complement C32.344
11Albumin10.285Apolipoprotein E24.3107Apolipoprotein E26.898
11Clusterin15.4178Clusterin16.7129
11Fibrinogen alpha chain9.7107Fibrinogen alpha chain11.086
11Fibronectin 13.076Fibrinogen gamma chain10.285
12Apolipoprotein E19.966Apolipoprotein E42.33615Apolipoprotein E34.73113
12Serum albumin18.798Fibrinogen alpha chain11.975Fibrinogen alpha chain10.7128
12Fibrinogen alpha chain6.164Fibrinogen gamma chain10.296Fibrinogen gamma chain10.6106
12Fibronectin 13.4128
13Uncharacterized protein17.2128Fibronectin 13.055
14Albumin19.91110Actin, beta12.344Tyrosine 3-monooxygenase/
tryptophan 5-monooxygenase
activation protein, zeta
polypeptide (Fragment)
22.854
15Apolipoprotein A-I24.1114